Literature DB >> 19287056

Demographic & clinical profile of HIV infected children accessing care at Tambaram, Chennai, India.

S Rajasekaran1, L Jeyaseelan, K Raja, N Ravichandran.   

Abstract

BACKGROUND &
OBJECTIVE: Human immunodeficiency virus (HIV) is severely affecting the poorly educated and economically disadvantaged in Indian society. When children start developing clinical manifestations, needing treatment, they have to travel long distances for accessing care and support at tertiary institutions. This places an extra burden on patients, who are already struggling to cope with their illness. Sufficient data are needed for the government to evolve appropriate policy for providing care to the children affected with HIV. We undertook this study to present the socio-demographic characteristics, signs and symptoms, clinical profile, distance travelled and follow up pattern of HIV positive children who accessed care for the first time in a referral hospital at Chennai, India.
METHODS: Electronic medical records from patients diagnosed with HIV between 2002 and 2004 at the Government Hospital for Thoracic Medicine (GHTM) in Tambaram (Chennai) in India were analyzed to understand care-seeking behaviours. Demographic variables such as age, sex, education and occupation, data on clinical manifestations were examined together with geographic information.
RESULTS: At GHTM 1,768 new paediatric patients accessed care from 2002 to 2004. Children aged less than 5 yr were 49.9 per cent; 1115 children had (63%) tuberculosis. Significantly, 14.9 and 20.6 per cent children had extra-pulmonary TB and disseminated TB respectively. Lower respiratory infection (15.8%), Pneumocystis carinii pneumonia (15.20%), oral/oesophageal candidiasis (13.5%), wasting (6.1%) and diarrhoeal disorders (3.5%) were the common clinical manifestations. In all 47 per cent children traveled between 200-400 km from home and 14 per cent travelled over 400 km. INTERPRETATION &
CONCLUSION: Our findings showed that tuberculosis should be regarded as the indicator disease for HIV infection in children, especially when they have clinical manifestations of progressive, non pulmonary and disseminated disease. The primary and secondary health care centres should have the trained capacity to diagnose and treat HIV disease and opportunistic infections so as the children to have much needed care and support nearer to their residence.

Entities:  

Mesh:

Year:  2009        PMID: 19287056

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  5 in total

1.  Otorhinolaryngological Manifestations among HIV Positive Children in Coastal Karnataka.

Authors:  Chetan Mandelia; Suja Sreedharan
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.

Authors:  Wasana Prasitsuebsai; Azar Kariminia; Thanyawee Puthanakit; Pagakrong Lumbiganon; Rawiwan Hansudewechakul; Fong Siew Moy; Matthew Law; Nagalingeswaran Kumarasamy; Kamarul Razali; Virat Sirisanthana; Annette H Sohn; Kulkanya Chokephaibulkit
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

3.  Predictors of Hospitalization among Children on ART in Ethiopia: a Cohort study.

Authors:  Abraham Haileamlak; Tesfalem Hagos; Workeabeba Abebe; Loko Abraham; Henok Asefa; Alula M Teklu
Journal:  Ethiop J Health Sci       Date:  2017-02

4.  Factors affecting adherence to treatment in children living with HIV.

Authors:  Deepshikha Verma; Damodar Bachani; Anita Shankar Acharya; Anju Seth; Alok Hemal
Journal:  Indian J Sex Transm Dis AIDS       Date:  2020-07-31

Review 5.  Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Authors:  David M Lowe; Molebogeng X Rangaka; Fabiana Gordon; Chris D James; Robert F Miller
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.